| Structure |
Chemical Name |
CAS |
MF |
 |
1-(3,4-Dichlorphenyl)-5-isopropylbiguanidmonohydrochlorid |
6001-93-0 |
C11H16Cl3N5 |
 |
Hemoglobin HbA0 (non-glycated) |
|
|
|
|
Abacavir Related CoMpounds Mixture |
|
|
 |
FOSCARNET IMPURITY B |
55920-24-6 |
C3H8NaO5P |
|
|
OXFENDAZOLE IMPURITY B |
|
|
|
|
Vancomycin B with Monodechlorovancomycin |
|
|
|
|
AMIODARONE IMPURITY D |
|
|
 |
70476-82-3 |
70476-82-3 |
|
|
|
CitalopraM Related CoMpound G |
|
|
|
|
CeftazidiMe, Delta-3-IsoMer |
|
|
 |
CHLORAMPHENICOL DISODIUM DISUCCINATE |
|
C19H20Cl2N2Na2O13-2 |
|
|
TRIMETHOPRIM IMPURITY B |
|
|
|
|
DANAPAROID SODIUM |
|
|
|
|
Cefprozil Related CoMpound H |
|
|
 |
Temazepam Related Compound F (15 mg) (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) |
3294-96-0 |
C16H13ClN2O2 |
 |
ZINC-64 |
|
Zn |
|
|
FLECAINIDE IMPURITY A |
|
|
|
|
ESKETAMINE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
|
|
Abacavir StereoisoMers Mixture |
|
|
|
|
Chloroquine Related CoMpound G |
|
|
![3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride](/CAS/20200119/GIF/CB12541748.gif) |
3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride |
|
C32H40ClNO4 |
 |
92-54-6 |
92-54-6 |
C10H14N2 |
|
|
dihydrovinpocetine |
|
|
 |
Abacavir Related CoMpound D |
1443421-69-9 |
C18H21ClN10O |
|
|
SalMeterol Related CoMpound A |
|
|
|
|
(R)-TIMOLOL |
|
|
 |
picotamide monohydrate |
80530-63-8 |
|
|
|
Anastrozole iMpurity E |
|
|
|
|
Orlistat Related CoMpound E |
|
|
|
|
SuMatriptan Succinate Related CoMpound C |
|
|
 |
ARTICAINE IMPURITY A |
1712677-79-6 |
C12H18N2O3S |
|
|
EUROSOIL 1 |
|
|
 |
96946-42-8 |
96946-42-8 |
|
 |
Cadmium-111Cd solution |
|
Cd |
![Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione)](/CAS/20200515/GIF/160596-25-8.gif) |
Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) |
160596-25-8 |
C18H17N3O3S |
 |
TIAPRIDE N-OXIDE |
63484-11-7 |
C15H24N2O5S |
|
|
ACECLOFENAC - REFERENCE SPECTRUM |
|
|
|
|
Silicon (isotope ratio) |
|
|
|
|
Risperidone Related CoMpounds Mixture |
|
|
 |
SalMeterol Resolution Check |
|
C25H37NO4 |
 |
Octadecylhydrogenmaleat |
2424-62-6 |
C22H40O4 |
 |
IFOSFAMIDE IMPURITY E |
42453-19-0 |
C5H11Cl2N |
|
|
HEPARIN LOW-MOLECULAR-MASS FOR ASSAY BRP |
|
|
 |
Copper-65Cu solution |
|
Cu |
 |
Boron-11B solution |
|
BH3 |
|
|
Platinum (isotope ratio) |
|
|
 |
SulfaMethoxazole Related CoMpound F |
17103-52-5 |
C10H11N3O3S |
![3-[(2,2-dimethoxyethyl)thio]propene](/CAS/GIF/84522-35-0.gif) |
3-[(2,2-dimethoxyethyl)thio]propene |
84522-35-0 |
C7H14O2S |
 |
Cefadroxil Related CoMpound I |
147103-94-4 |
C16H17N3O5S |
|
|
CALCIUM ASCORBATE - REFERENCE SPECTRUM |
|
|
|
|
GMO Standard ERM-BF412, Maize Bt-11 |
|
|
 |
Temazepam Related Compound G (15 mg) (7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) |
93329-92-1 |
C17H15ClN2O2 |
|
|
MetaMizole iMpurity E |
|
|
|
|
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM |
|
|
|
|
Interferonbeta1a/Humaninterferonbeta1a |
145258-61-3 |
|
|
|
Megestrol Acetate IMpurity K |
|
|
|
|
Medroxyprogesterone Acetate Related CoMpound A |
|
|
|
|
EUROSOIL 2 |
|
|
|
|
TRANS-EPOXYPHYTOMENADIONE |
|
|
 |
N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid 2-hydroxyethyl ester |
32508-98-8 |
C16H14F3NO3 |
|
|
PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
|
|
EUROSOIL 5 |
|
|
|
|
Enrofloxacin Related CoMpound Mixture |
|
|
|
|
INTERFERON GAMMA 1 B |
98059-61-1 |
|
 |
OXOLINIC ACID IMPURITY A |
26893-27-6 |
C11H7NO5 |
|
|
DICLAZURIL FOR VETERINARY USE - REFERENCE SPECTRUM |
|
|
|
|
TRICLOSAN RELATED COMPOUNDS MIXTURE A (1.2 ML/AMPULE; 3 AMPULES) |
|
|
-6-cyano-1(3H)-isobenzofuranone oxalate](/CAS/20200119/GIF/CB32541601.gif) |
3-[3-(diMethylaMino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
|
C22H21FN2O6 |
|
|
Levothyroxine for Peak Identification |
|
|
|
|
AMIODARONE IMPURITY E |
|
|
|
|
Naratriptan Resolution Mixture |
|
|
|
|
Pharmaceutical glass containers (Alkali leaching and release) |
|
|
|
|
Resin bonded glass fibreboard (thermal conductivity) |
|
|
 |
OseltaMivir IMpurity A |
1364932-19-3 |
C14H24N2O4 |
 |
METHYLTHIONINIUM IMPURITY A |
1231958-32-9 |
C16H18N3S+ |
|
|
POLYGLYCERYL-3 DIISOSTEARATE |
66082-42-6 |
C45H88O9 |
|
|
RETINOL ESTERS |
|
|
|
|
Vitamin D Assay System Suitability |
|
|
|
|
ARTICAINE IMPURITY E |
|
|
|
|
EUROSOIL 3 |
|
|
|
|
OMeprazole Related CoMpound F and G Mixture |
|
|
 |
ALLOPURINOL IMPURITY A |
|
C5H4N4O |
 |
IFOSFAMIDE IMPURITY B |
241482-18-8 |
C10H24Cl2N2O7P2 |
|
|
Lamivudine Resolution Mixture B |
|
|
 |
137234-62-9 |
137234-62-9 |
C16H14F3N5O |
 |
Iron-57Fe solution |
|
Fe |
 |
Rubidium-85Rb solution |
|
Rb |
|
|
Boric acid (isotope ratio) |
|
|
 |
TICARCILLIN IMPURITY A |
6933-26-2 |
C13H12OS |
 |
TRAMADOL IMPURITY A |
|
C16H25NO2 |
|
|
TYLOSIN PHOSPHATE FOR PEAK IDENTIFICATION |
|
|
 |
67392-87-4 |
67392-87-4 |
|
 |
(S)-1-(3-((ethyl(methyl)carbamoyl)oxy)phenyl)-N,N-dimethylethanamine |
415973-05-6 |
C14H22N2O2 |
|
|
Abacavir Related CoMpound B |
|
|
|
|
GalantaMine HydrobroMide Related CoMpounds Mixture |
|
|
 |
Ranitidine Resolution Mixture |
|
C13H22N4O3S |
|
|
ENDOTOXIN STANDARD |
|
|
|
|
HYDROUS BENZOYL PEROXIDE - REFERENCE SPECTRUM |
|
|
 |
ESTRADIOL FOR PEAK IDENTIFICATION |
|
C18H24O2 |
 |
82999, 237NpO2 (V encapsulated) |
58670-16-9 |
NpO2 |